The fact that EV priming increased the levels of tumor-infiltrating CD8+ T lymphocytes in EV-primed animals while the depletion of CD8+ T lymphocytes completely abrogated the beneficial impact of EV treatment suggests that these TEVs might provoke an antigen-specific T-cell response. Here, CD8A is linked to neoplasm.